Kemira Oyj Earnings Calls
| Release date | Oct 24, 2025 |
| EPS estimate | 0.340€ |
| EPS actual | 0.380€ |
| EPS Surprise | 11.76% |
| Revenue estimate | 704.55M |
| Revenue actual | 688M |
| Revenue Surprise | -2.35% |
| Release date | Jul 18, 2025 |
| EPS estimate | 0.410€ |
| EPS actual | 0.350€ |
| EPS Surprise | -14.56% |
| Revenue estimate | 712.867M |
| Revenue actual | 693.4M |
| Revenue Surprise | -2.73% |
| Release date | Apr 25, 2025 |
| EPS estimate | 0.398€ |
| EPS actual | 0.362€ |
| EPS Surprise | -9.16% |
| Revenue estimate | 697.202M |
| Revenue actual | 708.8M |
| Revenue Surprise | 1.66% |
| Release date | Feb 11, 2025 |
| EPS estimate | 0.440€ |
| EPS actual | 0.230€ |
| EPS Surprise | -47.73% |
| Revenue estimate | 767M |
| Revenue actual | 723.7M |
| Revenue Surprise | -5.65% |
Last 4 Quarters for Kemira Oyj
Below you can see how KEMIRA.HE performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Feb 11, 2025 |
| Price on release | 20.04€ |
| EPS estimate | 0.440€ |
| EPS actual | 0.230€ |
| EPS surprise | -47.73% |
| Date | Price |
|---|---|
| Feb 05, 2025 | 21.06€ |
| Feb 06, 2025 | 21.54€ |
| Feb 07, 2025 | 21.52€ |
| Feb 10, 2025 | 21.82€ |
| Feb 11, 2025 | 20.04€ |
| Feb 12, 2025 | 20.62€ |
| Feb 13, 2025 | 21.44€ |
| Feb 14, 2025 | 21.56€ |
| Feb 17, 2025 | 21.72€ |
| 4 days before | -4.84% |
| 4 days after | 8.38% |
| On release day | 2.89% |
| Change in period | 3.13% |
| Release date | Apr 25, 2025 |
| Price on release | 18.11€ |
| EPS estimate | 0.398€ |
| EPS actual | 0.362€ |
| EPS surprise | -9.16% |
| Date | Price |
|---|---|
| Apr 17, 2025 | 19.56€ |
| Apr 22, 2025 | 19.69€ |
| Apr 23, 2025 | 20.04€ |
| Apr 24, 2025 | 19.96€ |
| Apr 25, 2025 | 18.11€ |
| Apr 28, 2025 | 17.87€ |
| Apr 29, 2025 | 17.92€ |
| Apr 30, 2025 | 18.15€ |
| May 02, 2025 | 18.21€ |
| 4 days before | -7.41% |
| 4 days after | 0.552% |
| On release day | -1.33% |
| Change in period | -6.90% |
| Release date | Jul 18, 2025 |
| Price on release | 18.60€ |
| EPS estimate | 0.410€ |
| EPS actual | 0.350€ |
| EPS surprise | -14.56% |
| Date | Price |
|---|---|
| Jul 14, 2025 | 18.59€ |
| Jul 15, 2025 | 18.62€ |
| Jul 16, 2025 | 18.40€ |
| Jul 17, 2025 | 18.57€ |
| Jul 18, 2025 | 18.60€ |
| Jul 21, 2025 | 18.46€ |
| Jul 22, 2025 | 18.64€ |
| Jul 23, 2025 | 19.29€ |
| Jul 24, 2025 | 19.42€ |
| 4 days before | 0.0538% |
| 4 days after | 4.41% |
| On release day | -0.753% |
| Change in period | 4.46% |
| Release date | Oct 24, 2025 |
| Price on release | 20.44€ |
| EPS estimate | 0.340€ |
| EPS actual | 0.380€ |
| EPS surprise | 11.76% |
| Date | Price |
|---|---|
| Oct 20, 2025 | 18.96€ |
| Oct 21, 2025 | 18.98€ |
| Oct 22, 2025 | 19.12€ |
| Oct 23, 2025 | 19.48€ |
| Oct 24, 2025 | 20.44€ |
| Oct 27, 2025 | 19.31€ |
| Oct 28, 2025 | 18.95€ |
| Oct 29, 2025 | 19.23€ |
| Oct 30, 2025 | 19.02€ |
| 4 days before | 7.81% |
| 4 days after | -6.95% |
| On release day | -5.53% |
| Change in period | 0.316% |
Kemira Oyj Earnings Call Transcript Summary of Q3 2025
Kemira reported Q3 results with a 5% year‑on‑year revenue decline (3% organic) driven by weaker end‑markets across Packaging & Hygiene, Fiber Essentials and industrial water; a significant FX headwind from a weaker USD also contributed. Despite softer volumes, the company preserved strong profitability, delivering ~20% operative EBITDA margin overall and 23.1% in Water Solutions, helped by price stability, cost containment and favorable mix in PHS. Management emphasized continued strategic investment: acquisition of Water Engineering (pro‑forma revenue > USD 60m; purchase price ~USD 150m) to enter industrial water services, investments in PFAS/micropollutant capabilities (activated carbon reactivation site in Helsingborg, UK asset), and progress on a joint venture with IFF for bio‑based polymers (now expected in 2028 vs earlier guidance of end‑2027). A profitability improvement / operating‑model program in Packaging & Hygiene Solutions is underway with expected visible effects in 2027. Balance sheet remains strong, net debt stable, and a share buyback (up to EUR 100m / 5m shares) is nearly complete (~EUR 40m repurchased in Q3). Management kept its outlook unchanged but reiterated the need to focus on volumes, operational excellence and M&A to reach long‑term targets (organic growth >4% p.a., operative EBITDA 18–21%, ROCE >16%).
Sign In
Buy KEMIRA